Event Type
Disclosure
Voluntary
Variant
8-K
(including Exhibits 99.1 and 99.2) shall not be deemed to be “filed” for purposes of, or otherwise subject to the liabilities of, Section 18 of the Securities E
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Aquestive Therapeutics, Inc. Press Release, dated February 2, 2026 99.2 Aquesti